🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The fluoropyrimidines 5-fluorouracil (5FU) and capecitabine (Cp) are among ...
Status
Completed
Location
Inselspital
Start Date
2012-10
Trial ID
NCT01641458
This is an open-label, multicenter Phase 2 clinical study designed to evalu...
Status
Recruiting
Location
Shanghai East Hospital
Start Date
2026-04-25
Trial ID
NCT07503756
Treatments Being Tested
A single institution, single arm, two-cohort feasibility trial to evaluate ...
Status
Recruiting
Location
Icahn School of Medicine at Mount Sinai
Start Date
2026-03-26
Trial ID
NCT07059494
Treatments Being Tested
The purpose of this study was to demonstrate superiority of treatment with ...
Status
Completed
Location
Comprehensive Blood & Cancer Center
Start Date
2015-12-24
Trial ID
NCT02625610
This clinical trial is designed to assess the efficacy and safety of the tr...
Status
Recruiting
Location
Yale Cancer Center
Start Date
2025-02-27
Trial ID
NCT06731478
Treatments Being Tested
This expanded access study will assess the safety and efficacy of intraveno...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT01169558
Treatments Being Tested
The main objective is to evaluate progression-free survival (PFS) at 4 mont...
Status
Completed
Location
Centre rené Gauducheau
Start Date
2010-12
Trial ID
NCT01442649
Treatments Being Tested
The goal of this clinical trial is to establish guidelines for fluoropyrimi...
Status
Recruiting
Location
CHU Amiens
Start Date
2025-01-20
Trial ID
NCT06475352
Treatments Being Tested
Esophageal squamous cell carcinoma is considerably more prevalent in East A...
Status
Completed
Location
Multiple Locations
Start Date
2012-03
Trial ID
NCT01472419
The goal of this clinical trial is to test the safety of the trifluridine/t...
Status
Recruiting
Location
CHU Amiens
Start Date
2025-03-21
Trial ID
NCT06245356
Treatments Being Tested